BNA’s Health Care Daily Report™ sets the standard for reliable, high-intensity coverage of breaking health care news, covering all major legal, policy, industry, and consumer developments in a...
June 3 — Medicare should reconsider its plan to keep gender reassignment coverage decisions in the hands of local contractors, advocates for the transgender community said June 3.
Failure to extend coverage for gender reassignment procedures on a national basis will hurt those with gender dysphoria, Dan Bruner, senior director of policy at Whitman-Walker Health, told Bloomberg BNA.
Contrary to what the Centers for Medicare & Medicaid Services asserted June 2 in its proposed decision memo, there is significant evidence indicating that gender reassignment surgeries help people suffering with gender dysphoria, Bruner said. Whitman-Walker Health is a federally qualified health center in the nation's capital that serves lesbian, gay, bisexual and transgender persons and their families.
The CMS explained that gender dysphoria, previously known as gender identity disorder, is “a classification used to describe persons who experience significant discontent with their biological sex and/or birth gender.” Researchers have found that 0.5 percent of individuals are transgender, the memo said.
Local Medicare administrative contractors should continue determining whether beneficiaries should receive coverage for the gender reassignment procedures, the proposed decision memo said (107 HCDR, 6/3/16).
The CMS launched the national coverage determination process for the reassignment procedures in December 2015 (233 HCDR, 12/4/15). Making a national coverage determination would take local contractors out of the process.
Comments received by the CMS after it started the national coverage determination process, which were due in January, indicated insurers and providers backed national Medicare coverage for the surgeries. A Bloomberg BNA analysis of the 106 comments received on the matter by the January deadline found no private or public organization of national recognition wrote the agency to oppose the reassignment surgery national coverage determination process (03 HCDR, 1/6/16).
Leaving coverage decisions to contractors would mean beneficiaries, providers and the contractors would remain confused about Medicare's ability to pay for gender reassignment surgeries, Anand Kalra, the health programs manager at the Transgender Law Center in Oakland, Calif., said.
Hopes were raised that the CMS would start paying for the surgeries nationally after the Health and Human Services Departmental Appeals Board, in 2014, invalidated a policy that blocked Medicare coverages of the procedures, Kalra told Bloomberg BNA.
According to the website for the National Center for Transgender Equality, the DAB's 2014 decision invalidated the Medicare policy of categorically excluding coverage of “transition-related surgery, regardless of medical need.” The group said this means coverage decisions will be made on an individual basis.
The decision to keep local contractors in charge of coverage determinations may mean the CMS is misinterpreting the DAB's ruling, Kalra said. Furthermore, he said that the proposed decision memo shows there's confusion within the CMS about how to handle coverage of the reassignment procedures.
The CMS is asking for comments (under reference number CAG-00446N) on the proposed decision memo by July 2, according to a separate agency tracking sheet.
In the interim, Whitman-Walker Health will continue to pursue individual claims for coverage that the clinic is handling for its patients, Bruner said. The health clinic also intends to file comments on the proposed decision memo and will urge the CMS to cover gender reassignments on a national basis, he said.
Kalra urged the CMS to look at the evidence. The CMS needs “to make sure that their analysis reflect the most current understanding of the evidence,” he said, adding that major professional societies, such as the American Medical Association and the Endocrine Society, have found that gender reassignment surgery is a useful treatment for people with gender dysphoria.
A final decision on whether to cover the gender reassignment surgeries on a national level should be issued by Aug. 31, according to the tracking sheet.
To contact the reporter on this story: Michael D. Williamson in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Brian Broderick at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)